These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24123344)

  • 1. Implications of high antifungal susceptibility on Schizophyllum commune-associated allergy in clinical practice.
    Ogawa H; Fujimura M; Ohkura N; Makimura K
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5783. PubMed ID: 24123344
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to "implications of high antifungal susceptibility on Schizophyllum commune-associated allergy in clinical practice".
    Chowdhary A; Kathuria S; Agarwal K; Meis JF
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5784-5. PubMed ID: 24123345
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular characterization and in vitro antifungal susceptibility profile of Schizophyllum commune, an emerging basidiomycete in bronchopulmonary mycoses.
    Chowdhary A; Kathuria S; Singh PK; Agarwal K; Gaur SN; Roy P; Randhawa HS; Meis JF
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2845-8. PubMed ID: 23507274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergic Bronchopulmonary Mycosis Due to Schizophyllum commune Treated Effectively with Voriconazole.
    Ishiguro T; Kagiyama N; Kojima A; Yamada M; Nakamoto Y; Takaku Y; Shimizu Y; Kurashima K; Takayanagi N
    Intern Med; 2018 Sep; 57(17):2553-2557. PubMed ID: 29607966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two cases of Schizophyllum asthma: is this a new clinical entity or a precursor of ABPM?
    Ogawa H; Fujimura M; Takeuchi Y; Makimura K
    Pulm Pharmacol Ther; 2011 Oct; 24(5):559-62. PubMed ID: 21549852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Three cases of allergic bronchopulmonary mycosis due to Schizophyllum commune].
    Masunaga A; Morimoto K; Ando T; Ikushima S; Takemura T; Oritsu M
    Nihon Kokyuki Gakkai Zasshi; 2010 Dec; 48(12):912-7. PubMed ID: 21226297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of otitis externa caused by Schizophyllum commune: An approach to antimicrobial stewardship using Gram staining of otorrhea in a medical clinic.
    Maeda M; Maeda T; Nakamura A; Komatsu M
    J Infect Chemother; 2019 Sep; 25(9):731-734. PubMed ID: 30905630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Schizophyllum sensitization on decline of lung function in asthma.
    Ogawa H; Fujimura M; Takeuchi Y; Makimura K
    J Asthma; 2013 Sep; 50(7):764-8. PubMed ID: 23725350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort.
    Hiemenz JW; Raad II; Maertens JA; Hachem RY; Saah AJ; Sable CA; Chodakewitz JA; Severino ME; Saddier P; Berman RS; Ryan DM; Dinubile MJ; Patterson TF; Denning DW; Walsh TJ
    Eur J Clin Microbiol Infect Dis; 2010 Nov; 29(11):1387-94. PubMed ID: 20703506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucoamylase is a major allergen of Schizophyllum commune.
    Toyotome T; Satoh M; Yahiro M; Watanabe A; Nomura F; Kamei K
    Clin Exp Allergy; 2014 Mar; 44(3):450-7. PubMed ID: 24372664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The definitive diagnostic process and successful treatment for ABPM caused by Schizophyllum commune: a report of two cases.
    Ogawa H; Fujimura M; Takeuchi Y; Makimura K; Satoh K
    Allergol Int; 2012 Mar; 61(1):163-9. PubMed ID: 22377527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Case of chronic necrotizing pulmonary aspergillosis complicated by elevated eosinophils and serum IgE].
    Morita H; Oguri T; Uemura T; Iwashima Y; Nakamura A; Sato S
    Nihon Kokyuki Gakkai Zasshi; 2010 Nov; 48(11):842-6. PubMed ID: 21141064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing intensive cytotoxic chemotherapy: A real-world comparison.
    Tormo M; Pérez-Martínez A; Calabuig M; Hernández-Boluda JC; Amat P; Navarro D; Solano C
    Mycoses; 2018 Mar; 61(3):206-212. PubMed ID: 29125660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of lung surfactant proteins, SP-A and SP-D, and mannan binding lectin for therapy and genetic predisposition to allergic and invasive aspergillosis.
    Madan T
    Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):183-7. PubMed ID: 19075981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases.
    Nam HS; Jeon K; Um SW; Suh GY; Chung MP; Kim H; Kwon OJ; Koh WJ
    Int J Infect Dis; 2010 Jun; 14(6):e479-82. PubMed ID: 19910234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of short- and long-term treatment of itraconazole on chronic necrotizing pulmonary aspergillosis in multicenter study.
    Yoshida K; Kurashima A; Kamei K; Oritsu M; Ando T; Yamamoto T; Niki Y
    J Infect Chemother; 2012 Jun; 18(3):378-85. PubMed ID: 22526387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First report on cutaneous infectious granuloma caused by Schizophyllum commune.
    Tian L; Mu Y; Zhang H; Su X; Yang C; Shu X; Qing D
    BMC Infect Dis; 2018 Jun; 18(1):286. PubMed ID: 29940940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mucoid impaction of the bronchi caused by Schizophyllum commune which developed after discontinuation of itraconazole administration].
    Ishiguro T; Takayanagi N; Harasaw K; Yoshii Y; Matsushita A; Yoneda K; Miyahara Y; Kagiyama N; Tokunaga D; Aoki F; Saito H; Ubukata M; Kurashima K; Yanagisawa T; Sugita Y; Kawabata Y; Kamei K
    Nihon Kokyuki Gakkai Zasshi; 2009 Apr; 47(4):296-303. PubMed ID: 19455959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comments on practice guidelines for the diagnosis and management of aspergillosis made by the IDSA in 2016.
    Alarcón-Manoja E; Cardozo-Espinola C; Puerta-Alcalde P; García-Vidal C
    Rev Esp Quimioter; 2017 Sep; 30 Suppl 1():26-29. PubMed ID: 28882011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of in vivo triazole and echinocandin combination therapy for invasive pulmonary aspergillosis: enhanced efficacy against Cyp51 mutant isolates.
    Lepak AJ; Marchillo K; VanHecker J; Andes DR
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5438-47. PubMed ID: 23959322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.